Proton therapy in hepatocellular carcinoma
References
Westerly DC, Goodman KA. External Beam Radiation Therapy 9 for Liver Tumors: Simulation, Treatment Planning, and Advanced Delivery Techniques. In: Meyer J, Schefter T, editors. Radiation Therapy for Liver tumora. 1 ed: Springer International Publishing; 2017. p. 91-106.
Rath AK. Particle Radiotherapy: An introduction. In: Rath AK, Sahoo N, editors. Particle radiotherapy:Springer India; 2016. p. 1-6.
Knecht M, Wroe A, Yang GY. Particle Radiation Therapy for Liver Tumors: Simulation and Treatment Planning. In: Meyer J, Schefter T, editors. Radiation Therapy for Liver tumora. 1 ed: Springer International Publishing; 2017. p. 107-19.
อมรวิเชษฐ์ ณ. บทบาทของการฉายรังสีร่วมพิกัดในการรักษามะเร็งแพร่กระจายไปตับ. In: เลิศบุษยานุกูล ช, editor. มะเร็งวิวัฒน์ 2561. กรุงเทพมหานคร: โรงพิมพ์ เอส.ออฟเซ็ทกราฟฟิคดีไซน์; 2018. p. 14-26.
Gabrel V, Murat C, Thiele A. Recent advances in robust optimization: An overview. European Journal of Operational Research 2014;235:471-83.
Tsujii H, Tsuji H, Inada T, Maruhashi A, Hayakawa Y, Takada Y, et al. Clinical results of fractionated proton therapy. Int J Radiat Oncol Biol Phys 1993;25:49-60.
Matsuzaki Y, Osuga T, Saito Y, Chuganji Y, Tanaka N, Shoda J, et al. A new, effective, and safe therapeutic option using proton irradiation for hepatocellular carcinoma. Gastroenterology 1994;106:1032-41.
Chiba T, Tokuuye K, Matsuzaki Y, Sugahara S, Chuganji Y, Kagei K, et al. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 2005;11:3799-805.
Mizumoto M, Tokuuye K, Sugahara S, Nakayama H, Fukumitsu N, Ohara K, et al. Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. Int J Radiat Oncol Biol Phys 2008;71:462-7.
Fukumitsu N, Sugahara S, Nakayama H, Fukuda K, Mizumoto M, Abei M, et al. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2009;74:831-6.
Nakayama H, Sugahara S, Tokita M, Fukuda K, Mizumoto M, Abei M, et al. Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience. Cancer 2009;115:5499-506.
Nakayama H, Sugahara S, Fukuda K, Abei M, Shoda J, Sakurai H, et al. Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract. Int J Radiat Oncol Biol Phys 2011;80:992-5.
Bush DA, Kayali Z, Grove R, Slater JD. The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial. Cancer 2011;117:3053-9.
Hong TS, Wo JY, Yeap BY, Ben-Josef E, McDonnell EI, Blaszkowsky LS, et al. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. J Clin Oncol 2016;34:460-8.
Kim TH, Park JW, Kim YJ, Kim BH, Woo SM, Moon SH, et al. Phase I dose-escalation study of proton beam therapy for inoperable hepatocellular carcinoma. Cancer Res Treat 2015;47:34-45.
16. Silva MF, Sherman M. Criteria for liver transplantation for HCC: What should the limits be? Journal of Hepatology 2011;55:1137-47.
Bush DA, Smith JC, Slater JD, Volk ML, Reeves ME, Cheng J, et al. Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis. Int J Radiat Oncol Biol Phys 2016;95:477-82.
Byrne T, Vargas H. HCC: The San Francisco Criteria. Contemporary Liver Transplantation: The Successful Liver Transplant Program 2016:1-5.
Available from: https://www.astro.org/uploadedFiles/_MAIN_SITE/Daily_Practice/Reimbursement/Model_Policies/Content_Pieces/ASTROPBTModelPolicy.pdf.
Pawarode A, Voravud N, Sriuranpong V, Kullavanijaya P, Patt YZ. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol 1998;21:386-91.
Hata M, Tokuuye K, Sugahara S, Kagei K, Igaki H, Hashimoto T, et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 2005;104:794-801.
Sugahara S, Nakayama H, Fukuda K, Mizumoto M, Tokita M, Abei M, et al. Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis. Strahlenther Onkol 2009;185:782-8.
Kim DY, Park JW, Kim TH, Kim BH, Moon SH, Kim SS, et al. Risk-adapted simultaneous integrated boostproton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis. Radiother Oncol 2017;122:122-9.
Lee SU, Park JW, Kim TH, Kim YJ, Woo SM, Koh YH, et al. Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Strahlenther Onkol 2014;190:806-14.
Mok KT, Wang BW, Lo GH, Liang HL, Liu SI, Chou NH, et al. Multimodality management of hepatocellular carcinoma larger than 10 cm. J Am Coll Surg 2003;197:730-8.
Sugahara S, Oshiro Y, Nakayama H, Fukuda K, Mizumoto M, Abei M, et al. Proton beam therapy for large hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2010;76:460-6.
Hashimoto T, Tokuuye K, Fukumitsu N, Igaki H, Hata M, Kagei K, et al. Repeated proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2006;65:196-202.
Oshiro Y, Mizumoto M, Okumura T, Fukuda K, Fukumitsu N, Abei M, et al. Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma. Radiother Oncol 2017;123:240-5.
Yeung R, Bowen SR, Chapman TR, MacLennan GT, Apisarnthanarax S. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies. Pract Radiat Oncol 2018;8:287-93.
Rath AK. Particle Radiotherapy: An introduction. In: Rath AK, Sahoo N, editors. Particle radiotherapy:Springer India; 2016. p. 1-6.
Knecht M, Wroe A, Yang GY. Particle Radiation Therapy for Liver Tumors: Simulation and Treatment Planning. In: Meyer J, Schefter T, editors. Radiation Therapy for Liver tumora. 1 ed: Springer International Publishing; 2017. p. 107-19.
อมรวิเชษฐ์ ณ. บทบาทของการฉายรังสีร่วมพิกัดในการรักษามะเร็งแพร่กระจายไปตับ. In: เลิศบุษยานุกูล ช, editor. มะเร็งวิวัฒน์ 2561. กรุงเทพมหานคร: โรงพิมพ์ เอส.ออฟเซ็ทกราฟฟิคดีไซน์; 2018. p. 14-26.
Gabrel V, Murat C, Thiele A. Recent advances in robust optimization: An overview. European Journal of Operational Research 2014;235:471-83.
Tsujii H, Tsuji H, Inada T, Maruhashi A, Hayakawa Y, Takada Y, et al. Clinical results of fractionated proton therapy. Int J Radiat Oncol Biol Phys 1993;25:49-60.
Matsuzaki Y, Osuga T, Saito Y, Chuganji Y, Tanaka N, Shoda J, et al. A new, effective, and safe therapeutic option using proton irradiation for hepatocellular carcinoma. Gastroenterology 1994;106:1032-41.
Chiba T, Tokuuye K, Matsuzaki Y, Sugahara S, Chuganji Y, Kagei K, et al. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 2005;11:3799-805.
Mizumoto M, Tokuuye K, Sugahara S, Nakayama H, Fukumitsu N, Ohara K, et al. Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. Int J Radiat Oncol Biol Phys 2008;71:462-7.
Fukumitsu N, Sugahara S, Nakayama H, Fukuda K, Mizumoto M, Abei M, et al. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2009;74:831-6.
Nakayama H, Sugahara S, Tokita M, Fukuda K, Mizumoto M, Abei M, et al. Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience. Cancer 2009;115:5499-506.
Nakayama H, Sugahara S, Fukuda K, Abei M, Shoda J, Sakurai H, et al. Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract. Int J Radiat Oncol Biol Phys 2011;80:992-5.
Bush DA, Kayali Z, Grove R, Slater JD. The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial. Cancer 2011;117:3053-9.
Hong TS, Wo JY, Yeap BY, Ben-Josef E, McDonnell EI, Blaszkowsky LS, et al. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. J Clin Oncol 2016;34:460-8.
Kim TH, Park JW, Kim YJ, Kim BH, Woo SM, Moon SH, et al. Phase I dose-escalation study of proton beam therapy for inoperable hepatocellular carcinoma. Cancer Res Treat 2015;47:34-45.
16. Silva MF, Sherman M. Criteria for liver transplantation for HCC: What should the limits be? Journal of Hepatology 2011;55:1137-47.
Bush DA, Smith JC, Slater JD, Volk ML, Reeves ME, Cheng J, et al. Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis. Int J Radiat Oncol Biol Phys 2016;95:477-82.
Byrne T, Vargas H. HCC: The San Francisco Criteria. Contemporary Liver Transplantation: The Successful Liver Transplant Program 2016:1-5.
Available from: https://www.astro.org/uploadedFiles/_MAIN_SITE/Daily_Practice/Reimbursement/Model_Policies/Content_Pieces/ASTROPBTModelPolicy.pdf.
Pawarode A, Voravud N, Sriuranpong V, Kullavanijaya P, Patt YZ. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol 1998;21:386-91.
Hata M, Tokuuye K, Sugahara S, Kagei K, Igaki H, Hashimoto T, et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 2005;104:794-801.
Sugahara S, Nakayama H, Fukuda K, Mizumoto M, Tokita M, Abei M, et al. Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis. Strahlenther Onkol 2009;185:782-8.
Kim DY, Park JW, Kim TH, Kim BH, Moon SH, Kim SS, et al. Risk-adapted simultaneous integrated boostproton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis. Radiother Oncol 2017;122:122-9.
Lee SU, Park JW, Kim TH, Kim YJ, Woo SM, Koh YH, et al. Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Strahlenther Onkol 2014;190:806-14.
Mok KT, Wang BW, Lo GH, Liang HL, Liu SI, Chou NH, et al. Multimodality management of hepatocellular carcinoma larger than 10 cm. J Am Coll Surg 2003;197:730-8.
Sugahara S, Oshiro Y, Nakayama H, Fukuda K, Mizumoto M, Abei M, et al. Proton beam therapy for large hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2010;76:460-6.
Hashimoto T, Tokuuye K, Fukumitsu N, Igaki H, Hata M, Kagei K, et al. Repeated proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2006;65:196-202.
Oshiro Y, Mizumoto M, Okumura T, Fukuda K, Fukumitsu N, Abei M, et al. Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma. Radiother Oncol 2017;123:240-5.
Yeung R, Bowen SR, Chapman TR, MacLennan GT, Apisarnthanarax S. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies. Pract Radiat Oncol 2018;8:287-93.
Downloads
Published
2018-12-27
How to Cite
1.
อมรวิเชษฐ์ ณ. Proton therapy in hepatocellular carcinoma. J Thai Assn of Radiat Oncol [Internet]. 2018 Dec. 27 [cited 2024 Dec. 21];24(2):74-80. Available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/203035
Issue
Section
Original articles
License
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารมะเร็งวิวัฒน์ ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับ และบุคคลากรท่านอื่น ๆ ใน สมาคมฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใดๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
